1 / 28

Retroviruses (chapter 65)

Retroviruses (chapter 65). Positive strand RNA viruses (5000-12000 bp) Enveloped Contain reverse transcriptase enzyme Copies RNA into DNA Cause chronic disease long after infection Due to integration of viral DNA into host chromosome.

saima
Download Presentation

Retroviruses (chapter 65)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Retroviruses (chapter 65) • Positive strand RNA viruses (5000-12000 bp) • Enveloped • Contain reverse transcriptase enzyme • Copies RNA into DNA • Cause chronic disease long after infection • Due to integration of viral DNA into host chromosome

  2. Figure 65-1 Morphologic distinction of retrovirions. The morphology and position of the nucleocapsid core are used to classify the viruses. A-type particles are immature intracytoplasmic forms that bud through the plasma membrane into mature B-type, C-type, and D-type particles.

  3. Figure 65-2 Electron micrographs of two retroviruses. A, Human immunodeficiency virus. Note the cone-shaped nucleocapsid in several of the virions. B, Human T-leukemia virus. Note the C-type morphology characterized by a central symmetrical nucleocapsid. (From Belshe RB, editor: Textbook of human virology, ed 2, St Louis, 1991, Mosby.)

  4. Figure 65-2 Electron micrographs of two retroviruses. A, Human immunodeficiency virus. Note the cone-shaped nucleocapsid in several of the virions. B, Human T-leukemia virus. Note the C-type morphology characterized by a central symmetrical nucleocapsid. (From Belshe RB, editor: Textbook of human virology, ed 2, St Louis, 1991, Mosby.)

  5. Figure 65-4 Genomic structure of human retroviruses. A, Human T-lymphotropic virus (HTLV-1). B, Human immunodeficiency virus (HIV-1). The genes are defined in Table 65-2 and Figure 65-7. Unlike the other genes of these viruses, production of the messenger RNA for tax and rex (HTLV-1) and tat and rev (HIV) requires excision of two intron units. HIV-2 has a similar genome map. The vpu for HIV-2 is termed vpx. LTR, Long-terminal repeat. Protein nomenclature for HIV: ca, capsid protein; in, integrase; ma, matrix protein; nc, nucleocapsid protein; pr, protease; rt, reverse transcriptasesu, surface glycoprotein component; tm, transmembrane glycoprotein component. (Redrawn from Belshe RB, editor: Textbook of human virology, ed 2, St Louis, 1991, Mosby.)

  6. Figure 65-5 The life cycle of human immunodeficiency virus (HIV). HIV binds to CD4 and chemokine co-receptors and enters by fusion. The genome is reverse transcribed into DNA in the cytoplasm and integrated into the nuclear DNA. Transcription and translation of the genome occur in a fashion similar to that of human T-lymphotropic virus (HTLV-1) (see Figure 65-7). The virus assembles at the plasma membrane and matures after budding from the cell. cDNA, complementary DNA. (Redrawn from Fauci AS: Science 239:617-622, 1988.)

  7. CD4+ cell

  8. Figure 65-6 Target cell binding of human immunodeficiency virus. (Redrawn from Balter M: Science 274:1988, 1996.)

  9. Figure 65-7 Transcription and translation of human T-leukemia virus (HTLV-1). (A similar but more complex approach is used for human immunodeficiency virus [HIV].). All HTLV-1 and HIV messenger RNA (mRNA) include the 5'-end of the genome. The mRNA for tax and rex requires excision of two sequences (red X), the gag-pol and env sequences. The other mRNAs, including the env mRNA, require excision of one sequence. Translation of these mRNAs produces polyproteins, which are subsequently cleaved. Gene nomenclature: env, Envelope glycoprotein; gag, group antigen gene; pol, polymerase; rex, regulator of splicing; tax, transactivator. Protein nomenclature: C, Carboxyl terminus of peptide CA, capsid; MA, matrix; N, amino terminus; NC, nucleocapsid; PR, protease; SU, surface component; TM, transmembrane component of envelope glycoprotein. Prefixes: gp, Glycoprotein; gPr, glycosylated precursor polyprotein; p, protein; PR, precursor polyprotein.

  10. Acquired Immune Deficiency Syndrome (AIDS) • caused by human immunodeficiency virus (HIV) • retrovirus • believed to have evolved in Africa from a monkey virus

  11. Figure 65-12 Upper estimates of cumulative global distribution of human immunodeficiency virus (HIV) infections as of the end of 2003. The estimated cumulative global total of HIV-infected adults in 2003 was approximately 46 million. Infection rates vary widely in different regions of the world. The highest rates are in sub-Saharan Africa. (Modified from AIDS Epidemic Update, Dec 2003 www.unaids.org)

  12. Transmission • direct exposure of person’s bloodstream to body fluid containing virus • groups most at risk are (descending order): • homosexual/bisexual men • intravenous drug users • heterosexuals who have intercourse with drug users, prostitutes, and bisexuals • transfusion patients and hemophiliacs • children born of infected mothers

  13. Figure 65-8 Pathogenesis of human immunodeficiency virus (HIV). HIV causes lytic and latent infection of CD4 T cells and persistent infection of cells of the monocyte macrophage family and disrupts neurons. The outcomes of these actions are immunodeficiency and acquired immune deficiency syndrome (AIDS) dementia. DTH, Delayed-type hypersensitivity. (Redrawn from Fauci AS: Science 239:617-622, 1988.)

  14. Clinical manifestations • four types of pathological changes • AIDS-related complex (ARC) • AIDS • central nervous system disease • AIDS-related cancers

  15. Figure 65-9 Time course and stages of human immunodeficiency virus (HIV) disease. A long clinical latency period follows the initial mononucleosis-like symptoms. The progressive decrease in the number of CD4 T cells, even during the latency period, allows opportunistic infections to occur. The stages in HIV disease are defined by the CD4 T-cell levels and occurrence of opportunistic diseases. ARC, acquired immune deficiency syndrome (AIDS)-related complex. (Redrawn from Redfield RR, Buske DS: Sci Am 259:90-98, 1988, updated 1996.)

  16. ARC • fever, malaise, headaches, macular rash, weight loss, lymph node enlargement, oral candidiasis, and presence of antibodies to HIV • occurs in first few months after infection; lasts 1 to 3 weeks • can develop to full-blown AIDS

  17. AIDS • progressive destruction of CD4+ cells leads to collapse of immune system • patient susceptible to opportunistic infections

  18. HIV pathogenesis • involves depletion of T cells, possibly by: • disruption of plasma membrane permeability • destruction by immune system cells due to presence of gp120 in membrane • syncytia formation • integration and transposition of HIV provirus • apoptosis • may cause disruption of balance between different T cell populations • may destroy or disable dendritic cells • HIV mutates rapidly, so that it evades immune system

  19. Apoptosis and AIDS

  20. Disease processes associated with AIDS

  21. Central nervous system disease • headaches, fever, subtle cognitive changes, abnormal reflexes, and ataxia • dementia and severe sensory and motor changes observed in advanced cases • autoimmune neuropathies, cerebrovascular disease, and brain tumors are common

  22. AIDS-related cancers • Kaposi’s sarcoma • caused by human herpesvirus 8 • carcinoma of mouth and rectum • B-cell lymphomas

  23. Treatment • immunodiagnostic tests for HIV antibodies or antigens • treatment involves: • antiviral agents • nucleoside analogue reverse transcriptase (RT) inhibitors (e.g., AZT) • nonnucleoside RT inhibitors (e.g., delavirdine) • protease inhibitors (e.g., indinavir) • treatment of opportunistic infections and cancer

  24. Prevention and control • screening and treatment of blood and blood products • education • protected sexual behaviors • search for vaccine is ongoing

  25. Leukemia • two types of leukemias caused by retroviruses • adult T-cell leukemia • hairy-cell leukemia • both retroviruses spread: • by transfusions of contaminated blood • by needle sharing • by sexual contact • across placenta • from mother’s milk • by mosquitoes

  26. Adult T-cell leukemia • caused by human T-cell lymphotropic virus I (HTLV-I), a retrovirus • integration of virus into host genome activates growth-promoting genes • death caused by proliferation of leukemia cells or from opportunistic infections • no treatment available

  27. Hairy-cell leukemia • caused by HTLV-II • chronic progressive lympho-proliferative disease • death usually caused by opportunistic infections • IFN-a n3 used for treatment

More Related